After 7 years watching this guy, you learn not to trust him at all.
I waiting for him to put a sticker on his forehead and say sorry for recommending BSX.
Inflation is in the way and each dollar of ABT asset will double in near future.
That is only the small part of ABT story. ABT nutrition business is poised to grow very high while other part of its business will trend up steadily. ABT has small debt, good cash position and high cash flow. ABT will grow both organically and thru acquisition. Some big investors are aware of above facts while some news media encouraging their investors for quick money in ABBV. ABBV is flying high but look at its debt that ABT unloaded and also time frame for its Humira that will go diown in 3 years. I bet to see ABBV trading 1/3 of ABT by 2015.
Humira patent expires in about 3 years and all revenue/income from this drug vanishes soon. ABT is smart to deal with this worry now and meanwhile unloads its debt by separating ABBV. Humira probably could not make as much as unloaded ABT debt. This is like selling Humira now for a very good primum. On the other hand, ABT will put time and money on other part of its business that is much more stable and has long term income.
I said it last time and you are seeing both C and BAC are doing better than JPM and WFC. That said, the time horizen is not one or two days. If you wait for 9 months for a baby to be born then why are you expecting a stock to hit its target just in 2 days?
Can you believe that BAC was traded at $3 then $5 and $7.
So, some day, when BAC is near $20, we will say: "can you believe that BAC was traded at low $12 in early MAY 2013".
Sentiment: Strong Buy